Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2014 (2014), Article ID 564949, 8 pages
http://dx.doi.org/10.1155/2014/564949
Research Article

The Role of e-NOS in Chronic Cholestasis-Induced Liver and Renal Injury in Rats: The Effect of N-Acetyl Cysteine

1Department of Surgery, Atakent Hospital, Acibadem University, Halkali, 34678 Istanbul, Turkey
2Department of Pathology, Baskent University Istanbul Hospital, Altunizade, 34567 Istanbul, Turkey
3Department of Gastroenterology, Florence Nightingale Hospital, Bilim University, Sisli, 34321 Istanbul, Turkey

Received 13 July 2014; Revised 20 October 2014; Accepted 21 October 2014; Published 9 November 2014

Academic Editor: Michel Kahaleh

Copyright © 2014 Yusuf Gunay et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. He, A. Mennone, J. L. Boyer, and S.-Y. Cai, “Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells,” Hepatology, vol. 53, no. 2, pp. 548–557, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Kountouras, B. H. Billing, and P. J. Scheuer, “Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat,” British Journal of Experimental Pathology, vol. 65, no. 3, pp. 305–311, 1984. View at Google Scholar · View at Scopus
  3. R. J. Sokol, B. M. Winklhofer-Roob, M. W. Devereaux, and J. M. McKim Jr., “Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids,” Gastroenterology, vol. 109, no. 4, pp. 1249–1256, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Pastor, P. S. Collado, M. Almar, and J. González-Gallego, “Antioxidant enzyme status in biliary obstructed rats: effects of N-acetylcysteine,” Journal of Hepatology, vol. 27, no. 2, pp. 363–370, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. M. D. M. Arriero, A. López-Farré, O. Fryeiro et al., “Expression of inducible nitric oxide synthase in the liver of bile duct-ligated Wistar rats with modulation by lymphomononuclear cells,” Surgery, vol. 129, no. 3, pp. 255–266, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. S. F. Assimakopoulos, C. E. Vagianos, N. Patsoukis, C. Georgiou, V. Nikolopoulou, and C. D. Scopa, “Evidence for intestinal oxidative stress in obstructive jaundice-induced gut barrier dysfunction in rats,” Acta Physiologica Scandinavica, vol. 180, no. 2, pp. 177–185, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Karageorgos, N. Patsoukis, E. Chroni, D. Konstantinou, S. F. Assimakopoulos, and C. Georgiou, “Effect of N-acetylcysteine, allopurinol and vitamin E on jaundice-induced brain oxidative stress in rats,” Brain Research, vol. 1111, no. 1, pp. 203–212, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Ljubuncic, Z. Tanne, and A. Bomzon, “Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease,” Gut, vol. 47, no. 5, pp. 710–716, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Montini, C. Carasi, L. Zancan et al., “Chronic cholestatic liver disease with associated tubulointerstitial nephropathy in early childhood,” Pediatrics, vol. 100, no. 3, article E10, 1997. View at Google Scholar · View at Scopus
  10. M. Popović-Rolović, M. Kostić, M. Sindjić, O. Jovanović, A. Peco-Antić, and D. Kruscić, “Progressive tubulointerstitial nephritis and chronic cholestatic liver disease,” Pediatric Nephrology, vol. 7, no. 4, pp. 396–400, 1993. View at Google Scholar
  11. C. P. Armstrong, J. M. Dixon, T. V. Taylor, and G. C. Davies, “Surgical experience of deeply jaundiced patients with bile duct obstruction,” British Journal of Surgery, vol. 71, no. 3, pp. 234–238, 1984. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Uslu, F. A. Taşli, A. Nart et al., “Human kidney histopathology in acute obstructive jaundice: a prospective study,” European Journal of Gastroenterology and Hepatology, vol. 22, no. 12, pp. 1458–1465, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. H. J. Kramer, “Impaired renal function in obstructive jaundice: roles of the thromboxane and endothelin systems,” Nephron, vol. 77, no. 1, pp. 1–12, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Bomzon, S. Holt, and K. Moore, “Bile acids, oxidative stress, and renal function in biliary obstruction,” Seminars in Nephrology, vol. 17, no. 6, pp. 549–562, 1997. View at Google Scholar · View at Scopus
  15. M. P. Panozzo, D. Basso, L. Balint, M. Zaninotto, P. Bonvicini, and M. Plebani, “Renal functional alterations in extrahepatic cholestasis: can oxidative stress be involved?” European Surgical Research, vol. 27, no. 5, pp. 332–339, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. M. G. H. Betjes and I. Bajema, “The pathology of jaundice-related renal insufficiency: cholemic nephrosis revisited,” Journal of Nephrology, vol. 19, no. 2, pp. 229–233, 2006. View at Google Scholar · View at Scopus
  17. G. Vendemiale, I. Grattagliano, M. L. Caruso et al., “Increased oxidative stress in dimethylnitrosamine-induced liver fibrosis in the rat: effect of N-acetylcysteine and interferon-α,” Toxicology and Applied Pharmacology, vol. 175, no. 2, pp. 130–139, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Tsuji, Y. Miyake, H. Aono, Y. Kawashima, and S. Mita, “Effects of bucillamine and N-acetyl-L-cysteine on cytokine production and collagen-induced arthritis (CIA),” Clinical and Experimental Immunology, vol. 115, no. 1, pp. 26–31, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Pahan, F. G. Sheikh, A. M. S. Namboodiri, and I. Singh, “N-acetyl cysteine inhibits induction of no production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes,” Free Radical Biology and Medicine, vol. 24, no. 1, pp. 39–48, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. M. de Araujo, L. Andrade, T. M. Coimbra, A. C. Rodrigues Jr., and A. C. Seguro, “Magnesium supplementation combined with N-acetylcysteine protects against postischemic acute renal failure,” Journal of the American Society of Nephrology, vol. 16, no. 11, pp. 3339–3349, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Zafarullah, W. Q. Li, J. Sylvester, and M. Ahmad, “Molecular mechanisms of N-acetylcysteine actions,” Cellular and Molecular Life Sciences, vol. 60, no. 1, pp. 6–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. J. F. Xu, J. M. Qu, and H. P. Li, “N-acetylcysteine modulates acute lung injury induced by Pseudomonas aeruginosa in rats,” Clinical and Experimental Pharmacology and Physiology, vol. 38, no. 5, pp. 345–351, 2011. View at Publisher · View at Google Scholar
  23. P. Scheuer, “Primary biliary cirrhosis,” Proceedings of the Royal Society of Medicine, vol. 60, no. 12, pp. 1257–1260, 1967. View at Google Scholar · View at Scopus
  24. C. Brooks, Q. Wei, S.-G. Cho, and Z. Dong, “Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models,” The Journal of Clinical Investigation, vol. 119, no. 5, pp. 1275–1285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Kunugi, A. Shimizu, N. Kuwahara et al., “Inhibition of matrix metalloproteinases reduces ischemia-reperfusion acute kidney injury,” Laboratory Investigation, vol. 91, no. 2, pp. 170–180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S. F. Assimakopoulos, C. E. Vagianos, G. Zervoudakis et al., “Gut regulatory peptides bombesin and neurotensin reduce hepatic oxidative stress and histological alterations in bile duct ligated rats,” Regulatory Peptides, vol. 120, no. 1–3, pp. 185–193, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Kawamura, Y. Kobayashi, F. Kageyama et al., “Enhanced hepatic lipid peroxidation in patients with primary biliary cirrhosis,” The American Journal of Gastroenterology, vol. 95, no. 12, pp. 3596–3601, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Shiomi, Y. Wakabayashi, T. Sano et al., “Nitric oxide suppression reversibly attenuates mitochondrial dysfunction and cholestasis in endotoxemic rat liver,” Hepatology, vol. 27, no. 1, pp. 108–115, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. C. L. Davis, T. A. Gonwa, and A. H. Wilkinson, “Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I,” Liver Transplantation, vol. 8, no. 2, pp. 91–109, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Criado, O. Flores, M. C. Ortíz et al., “Elevated glomerular and blood mononuclear lymphocyte nitric oxide production in rats with chronic bile duct ligation: role of inducible nitric oxide synthase activation,” Hepatology, vol. 26, no. 2, pp. 268–276, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Mayoral, M. Criado, F. Hidalgo et al., “Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation,” Clinical Science, vol. 96, no. 3, pp. 297–305, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Shieh, M. Zhou, D. A. Ornan, I. H. Chaudry, and P. Wang, “Upregulation of inducible nitric oxide synthase and nitric oxide occurs later than the onset of the hyperdynamic response during sepsis,” Shock, vol. 13, no. 4, pp. 325–329, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. A. M. Miles, D. S. Bohle, P. A. Glassbrenner, B. Hansert, D. A. Wink, and M. B. Grisham, “Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide,” Journal of Biological Chemistry, vol. 271, no. 1, pp. 40–47, 1996. View at Publisher · View at Google Scholar · View at Scopus
  34. E. L. Conesa, F. Valero, J. C. Nadal et al., “N-acetyl-L-cysteine improves renal medullary hypoperfusion in acute renal failure,” American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 281, no. 3, pp. R730–R737, 2001. View at Google Scholar · View at Scopus
  35. V. Darley-Usmar, H. Wiseman, and B. Halliwell, “Nitric oxide and oxygen radicals: a question of balance,” The FEBS Letters, vol. 369, no. 2-3, pp. 131–135, 1995. View at Publisher · View at Google Scholar · View at Scopus
  36. M. H. Massola Shimizu, T. M. Coimbra, M. De Araujo, L. F. Menezes, and A. C. Seguro, “N-acetylcysteine attenuates the progression of chronic renal failure,” Kidney International, vol. 68, no. 5, pp. 2208–2217, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. S. N. Heyman, S. Rosen, M. Khamaisi, J.-M. Idée, and C. Rosenberger, “Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy,” Investigative Radiology, vol. 45, no. 4, pp. 188–195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Cuzzocrea, E. Mazzon, G. Costantino, I. Serraino, A. De Sarro, and A. P. Caputi, “Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury,” Cardiovascular Research, vol. 47, no. 3, pp. 537–548, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Galicia-Moreno, L. Favari, and P. Muriel, “Antifibrotic and antioxidant effects of N-acetylcysteine in an experimental cholestatic model,” European Journal of Gastroenterology and Hepatology, vol. 24, no. 2, pp. 179–185, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Singh, G. Shackleton, E. Ah-Sing, J. Chakraborty, and M. E. Bailey, “Antioxidant defenses in the bile duct-ligated rat,” Gastroenterology, vol. 103, no. 5, pp. 1625–1629, 1992. View at Google Scholar · View at Scopus
  41. M. Parola, G. Leonarduzzi, G. Robino, E. Albano, G. Poli, and M. U. Dianzani, “On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis,” Free Radical Biology and Medicine, vol. 20, no. 3, pp. 351–359, 1996. View at Publisher · View at Google Scholar · View at Scopus
  42. R. S. Britton and B. R. Bacon, “Role of free radicals in liver diseases and hepatic fibrosis,” Hepato-Gastroenterology, vol. 41, no. 4, pp. 343–348, 1994. View at Google Scholar · View at Scopus
  43. S.-I. Hagiwara, Y. Ishii, and S. Kitamura, “Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice,” The American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 1, pp. 225–231, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Pardo, V. Ruiz, J. L. Arreola et al., “Bleomycin-induced pulmonary fibrosis is attenuated in γ-glutamyl transpeptidase-deficient mice,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 6, pp. 925–932, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. W. Peres, M. J. Tuón, P. S. Collado, S. Herrmann, N. Marroni, and J. González-Gallego, “The flavonoid quercetin ameliorates liver damage in rats with biliary obstruction,” Journal of Hepatology, vol. 33, no. 5, pp. 742–750, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Pavanato, M. J. Tuñón, S. Sánchez-Campos, C. A. Marroni, S. Llesuy, and J. González-Gallego, “Effects of quercetin on liver damage in rats with carbon tetrachloride-induced cirrhosis,” Digestive Diseases and Sciences, vol. 48, no. 4, pp. 824–829, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Tieppo, R. Vercelino, A. S. Dias et al., “Evaluation of the protective effects of quercetin in the hepatopulmonary syndrome,” Food and Chemical Toxicology, vol. 45, no. 7, pp. 1140–1146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. G. Tahan, O. Tarcin, V. Tahan et al., “The effects of N-acetylcysteine on bile duct ligation-induced liver fibrosis in rats,” Digestive Diseases and Sciences, vol. 52, no. 12, pp. 3348–3354, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. M. de Araujo, L. Andrade, T. M. Coimbra, A. C. Rodrigues Jr., and A. C. Seguro, “Magnesium supplementation combined with N-acetylcysteine protects against postischemic acute renal failure,” Journal of the American Society of Nephrology, vol. 16, no. 11, pp. 3339–3349, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. P. L. Majano, J. Medina, I. Zubía et al., “N-Acetyl-cysteine modulates inducible nitric oxide synthase gene expression in human hepatocytes,” Journal of Hepatology, vol. 40, no. 4, pp. 632–637, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Caglikulekci, C. Pata, D. D. Apa et al., “The effect of N-acetylcysteine (NAC) on liver and renal tissue inducible nitric oxide synthase (iNOS) and tissue lipid peroxidation in obstructive jaundice stimulated by lipopolysaccharide (LPS),” Pharmacological Research, vol. 49, no. 3, pp. 227–238, 2004. View at Publisher · View at Google Scholar · View at Scopus